IgA: An immune glycoprotein

Clinical Immunology

Volumn 116, Issue 1, 2005, Pages 3-10

  Yoo, Esther M ^a   Morrison, Sherie L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glycoprotein; Glycosylation; Immunoglobulin; Recombinant antibodies

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; GLYCOPROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN RECEPTOR; PROTEINASE; RECOMBINANT IMMUNOGLOBULIN A; RECOMBINANT PROTEIN; SECRETORY COMPONENT; SECRETORY IMMUNOGLOBULIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; BACTERIAL INFECTION; DISEASE ASSOCIATION; GLYCOSYLATION; HUMAN; IMMUNITY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN A NEPHROPATHY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SERUM; SHORT SURVEY;

GLOMERULONEPHRITIS, IGA; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; MUCOUS MEMBRANE; PEPTIDE HYDROLASES; RECEPTORS, FC;

EID: 19544385446     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.03.010     Document Type: Short Survey

References (86)

1. K.R. Chintalacharuvu, L.J. Yu, N. Bhola, K. Kobayashi, C.Z. Fernandez, and S.L. Morrison Cysteine residues required for the attachment of the light chain in human IgA2 J. Immunol. 169 2002 5072 5077
2. A.B. Herr, E.R. Ballister, and P.J. Bjorkman Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc Nature 423 2003 614 620
3. E.M. Yoo, M.J. Coloma, K.R. Trinh, T.Q. Nguyen, L.U. Vuong, S.L. Morrison, and K.R. Chintalacharuvu Structural requirements for polymeric immunoglobulin assembly and association with J chain J. Biol. Chem. 274 1999 33771 33777
4. A. Rifai, K. Fadden, S.L. Morrison, and K.R. Chintalacharuvu The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes J. Exp. Med. 191 2000 2171 2182
5. T.S. Mattu, R.J. Pleass, A.C. Willis, M. Kilian, M.R. Wormald, A.C. Lellouch, P.M. Rudd, J.M. Woof, and R.A. Dwek The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc alpha receptor interactions J. Biol. Chem. 273 1998 2260 2272
6. S.R. Chintalacharuvu, N.U. Nagy, N. Sigmund, J.G. Nedrud, M.E. Amm, and S.N. Emancipator T cell cytokines determine the severity of experimental IgA nephropathy by regulating IgA glycosylation Clin. Exp. Immunol. 126 2001 326 333
7. S.R. Chintalacharuvu, and S.N. Emancipator The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines J. Immunol. 159 1997 2327 2333
8. A.K. Taylor, and R. Wall Selective removal of alpha heavy-chain glycosylation sites causes immunoglobulin A degradation and reduced secretion Mol. Cell. Biol. 8 1988 4197 4203
9. P.D. Chuang, and S.L. Morrison Elimination of N-linked glycosylation sites from the human IgA1 constant region: effects on structure and function J. Immunol. 158 1997 724 732
10. R. Gupta, and S. Brunak Prediction of glycosylation across the human proteome and the correlation to protein function Pac. Symp. Biocomput. 2002 310 322
11. H. Iwasaki, Y. Zhang, K. Tachibana, M. Gotoh, N. Kikuchi, Y.D. Kwon, A. Togayachi, T. Kudo, T. Kubota, and H. Narimatsu Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-d- galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 J. Biol. Chem. 278 2003 5613 5621
12. L. Royle, A. Roos, D.J. Harvey, M.R. Wormald, D. van Gijlswijk-Janssen, R.M. Redwan el, I.A. Wilson, M.R. Daha, R.A. Dwek, and P.M. Rudd Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems J. Biol. Chem. 278 2003 20140 20153
13. A. Phalipon, A. Cardona, J.P. Kraehenbuhl, L. Edelman, P.J. Sansonetti, and B. Corthesy Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo Immunity 17 2002 107 115
14. E. Lullau, S. Heyse, H. Vogel, I. Marison, U. von Stockar, J.P. Kraehenbuhl, and B. Corthesy Antigen binding properties of purified immunoglobulin A and reconstituted secretory immunoglobulin A antibodies J. Biol. Chem. 271 1996 16300 16309
15. K.R. Chintalacharuvu, and S.L. Morrison Production of secretory immunoglobulin A by a single mammalian cell Proc. Natl. Acad. Sci. U. S. A. 94 1997 6364 6368
16. J. Berdoz, C.T. Blanc, M. Reinhardt, J.P. Kraehenbuhl, and B. Corthesy In vitro comparison of the antigen-binding and stability properties of the various molecular forms of IgA antibodies assembled and produced in CHO cells Proc. Natl. Acad. Sci. U. S. A. 96 1999 3029 3034
17. K.E. Mostov Transepithelial transport of immunoglobulins Annu. Rev. Immunol. 12 1994 63 84
18. K.R. Chintalacharuvu, A.S. Tavill, L.N. Louis, J.P. Vaerman, M.E. Lamm, and C.S. Kaetzel Disulfide bond formation between dimeric immunoglobulin A and the polymeric immunoglobulin receptor during hepatic transcytosis Hepatology 19 1994 162 173
19. P. Brandtzaeg Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man Scand. J. Immunol. 22 1985 111 146
20. B.A. Hendrickson, D.A. Conner, D.J. Ladd, D. Kendall, J.E. Casanova, B. Corthesy, E.E. Max, M.R. Neutra, C.E. Seidman, and J.G. Seidman Altered hepatic transport of immunoglobulin A in mice lacking the J chain J. Exp. Med. 182 1995 1905 1911
21. C. Basset, V. Devauchelle, V. Durand, C. Jamin, Y.L. Pennec, P. Youinou, and M. Dueymes Glycosylation of immunoglobulin A influences its receptor binding Scand. J. Immunol. 50 1999 572 579
22. L. Carayannopoulos, E.E. Max, and J.D. Capra Recombinant human IgA expressed in insect cells Proc. Natl. Acad. Sci. U. S. A. 91 1994 8348 8352
23. I.C. Moura, M.N. Centelles, M. Arcos-Fajardo, D.M. Malheiros, J.F. Collawn, M.D. Cooper, and R.C. Monteiro Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy J. Exp. Med. 194 2001 417 425
24. I.C. Moura, M. Arcos-Fajardo, C. Sadaka, V. Leroy, M. Benhamou, J. Novak, F. Vrtovsnik, E. Haddad, K.R. Chintalacharuvu, and R.C. Monteiro Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy J. Am. Soc. Nephrol. 15 2004 622 634
25. Z. Moldoveanu, J.M. Epps, S.R. Thorpe, and J. Mestecky The sites of catabolism of murine monomeric IgA J. Immunol. 141 1988 208 213
26. J. Mestecky, Z. Moldoveanu, M. Tomana, J.M. Epps, S.R. Thorpe, J.O. Phillips, and R. Kulhavy The role of the liver in catabolism of mouse and human IgA Immunol. Invest. 18 1989 313 324
27. M. Tomana, R. Kulhavy, and J. Mestecky Receptor-mediated binding and uptake of immunoglobulin A by human liver Gastroenterology 94 1988 762 770
28. A. Shibuya, N. Sakamoto, Y. Shimizu, K. Shibuya, M. Osawa, T. Hiroyama, H.J. Eyre, G.R. Sutherland, Y. Endo, T. Fujita, T. Miyabayashi, S. Sakano, T. Tsuji, E. Nakayama, J.H. Phillips, L.L. Lanier, and H. Nakauchi Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes Nat. Immunol. 1 2000 441 446
29. N. Sakamoto, K. Shibuya, Y. Shimizu, K. Yotsumoto, T. Miyabayashi, S. Sakano, T. Tsuji, E. Nakayama, H. Nakauchi, and A. Shibuya A novel Fc receptor for IgA and IgM is expressed on both hematopoietic and non-hematopoietic tissues Eur. J. Immunol. 31 2001 1310 1316
30. K.J. McDonald, A.J. Cameron, J.M. Allen, and A.G. Jardine Expression of Fc alpha/mu receptor by human mesangial cells: a candidate receptor for immune complex deposition in IgA nephropathy Biochem. Biophys. Res. Commun. 290 2002 438 442
31. J. Barratt, M.R. Greer, I.Z. Pawluczyk, A.C. Allen, E.M. Bailey, K.S. Buck, and J. Feehally Identification of a novel Fcalpha receptor expressed by human mesangial cells Kidney Int. 57 2000 1936 1948
32. B.W. Senior, J.I. Dunlop, M.R. Batten, M. Kilian, and J.M. Woof Cleavage of a recombinant human immunoglobulin A2 (IgA2)-IgA1 hybrid antibody by certain bacterial IgA1 proteases Infect. Immun. 68 2000 463 469
33. K.R. Chintalacharuvu, P.D. Chuang, A. Dragoman, C.Z. Fernandez, J. Qiu, A.G. Plaut, K.R. Trinh, F.A. Gala, and S.L. Morrison Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA Infect. Immun. 71 2003 2563 2570
34. M.R. Batten, B.W. Senior, M. Kilian, and J.M. Woof Amino acid sequence requirements in the hinge of human immunoglobulin A1 (IgA1) for cleavage by streptococcal IgA1 proteases Infect. Immun. 71 2003 1462 1469
35. J. Reinholdt, M. Tomana, S.B. Mortensen, and M. Kilian Molecular aspects of immunoglobulin A1 degradation by oral streptococci Infect. Immun. 58 1990 1186 1194
36. H. Stubbe, J. Berdoz, J.P. Kraehenbuhl, and B. Corthesy Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers J. Immunol. 164 2000 1952 1960
37. Y.J. Gan, J. Chodosh, A. Morgan, and J.W. Sixbey Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus J. Virol. 71 1997 519 526
38. J.W. Sixbey, and Q.Y. Yao Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism Science 255 1992 1578 1580
39. A.J. Macpherson, and T. Uhr Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria Science 303 2004 1662 1665
40. C.S. Kaetzel, J.K. Robinson, K.R. Chintalacharuvu, J.P. Vaerman, and M.E. Lamm The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA Proc. Natl. Acad. Sci. U. S. A. 88 1991 8796 8800
41. M.I. Fernandez, T. Pedron, R. Tournebize, J.C. Olivo-Marin, P.J. Sansonetti, and A. Phalipon Anti-inflammatory role for intracellular dimeric immunoglobulin a by neutralization of lipopolysaccharide in epithelial cells Immunity 18 2003 739 749
42. A.C. Allen, E.M. Bailey, P.E. Brenchley, K.S. Buck, J. Barratt, and J. Feehally Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients Kidney Int. 60 2001 969 973
43. A. Amore, P. Cirina, G. Conti, P. Brusa, L. Peruzzi, and R. Coppo Glycosylation of circulating IgA in patients with IgA nephropathy modulates proliferation and apoptosis of mesangial cells J. Am. Soc. Nephrol. 12 2001 1862 1871
44. Y. Hiki, H. Odani, M. Takahashi, Y. Yasuda, A. Nishimoto, H. Iwase, T. Shinzato, Y. Kobayashi, and K. Maeda Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy Kidney Int. 59 2001 1077 1085
45. H. Odani, Y. Hiki, M. Takahashi, A. Nishimoto, Y. Yasuda, H. Iwase, T. Shinzato, and K. Maeda Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry Biochem. Biophys. Res. Commun. 271 2000 268 274
46. M.R. Greer, J. Barratt, S.J. Harper, A.C. Allen, and J. Feehally The nucleotide sequence of the IgA1 hinge region in IgA nephropathy Nephrol. Dial. Transplant. 13 1998 1980 1983
47. T. Sano, Y. Hiki, T. Kokubo, H. Iwase, H. Shigematsu, and Y. Kobayashi Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli Nephrol., Dial., Transplant. 17 2002 50 56
48. H. Iwase, S. Ohkawa, I. Ishii-Karakasa, Y. Hiki, T. Kokubo, T. Sano, A. Tanaka, K. Toma, Y. Kobayashi, and K. Hotta Study of the relationship between sticky human serum IgA1 and its O-glycan glycoform Biochem. Biophys. Res. Commun. 261 1999 472 477
49. C. Gomez-Guerrero, N. Duque, and J. Egido Stimulation of Fc(alpha) receptors induces tyrosine phosphorylation of phospholipase C-gamma(1), phosphatidylinositol phosphate hydrolysis, and Ca2+ mobilization in rat and human mesangial cells J. Immunol. 156 1996 4369 4376
50. J.C. Leung, S.C. Tang, L.Y. Chan, A.W. Tsang, H.Y. Lan, and K.N. Lai Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy Nephrol. Dial. Transplant. 18 2003 36 45
51. K.N. Lai, S.C. Tang, J.Y. Guh, T.D. Chuang, M.F. Lam, L.Y. Chan, A.W. Tsang, and J.C. Leung Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system J. Am. Soc. Nephrol. 14 2003 3127 3137
52. J. Novak, H.L. Vu, L. Novak, B.A. Julian, J. Mestecky, and M. Tomana Interactions of human mesangial cells with IgA and IgA-containing immune complexes Kidney Int. 62 2002 465 475
53. P.J. van der Boog, J.W. De Fijter, C. Van Kooten, R. Van Der Holst, A. Van Seggelen, L.A. Van Es, and M.R. Daha Complexes of IgA with FcalphaRI/CD89 are not specific for primary IgA nephropathy Kidney Int. 63 2003 514 521
54. S.C. Diven, C.R. Caflisch, D.K. Hammond, P.H. Weigel, J.A. Oka, and R.M. Goldblum IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD 89) Kidney Int. 54 1998 837 847
55. P. Launay, B. Grossetete, M. Arcos-Fajardo, E. Gaudin, S.P. Torres, L. Beaudoin, N. Patey-Mariaud de Serre, A. Lehuen, and R.C. Monteiro Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice J. Exp. Med. 191 2000 1999 2009
56. M. Tomana, J. Novak, B.A. Julian, K. Matousovic, K. Konecny, and J. Mestecky Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies J. Clin. Invest. 104 1999 73 81
57. T. Kokubo, K. Hashizume, H. Iwase, K. Arai, A. Tanaka, K. Toma, K. Hotta, and Y. Kobayashi Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy Nephrol. Dial. Transplant. 15 2000 28 33
58. S. Kimura, A. Horie, Y. Hiki, C. Yamamoto, S. Suzuki, J. Kuroda, M. Deguchi, G. Kato, T. Karasuno, A. Hiraoka, T. Yoshikawa, and T. Maekawa Nephrotic syndrome with crescent formation and massive IgA deposition following allogeneic bone marrow transplantation for natural killer cell leukemia/lymphoma Blood 101 2003 4219 4221
59. L.A. Chan, J.B. Lyczak, K. Zhang, S.L. Morrison, and A. Saxon The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex Mol. Immunol. 37 2000 241 252
60. A.C. Allen, F.R. Willis, T.J. Beattie, and J. Feehally Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis Nephrol. Dial. Transplant. 13 1998 930 934
61. C. Basset, V. Durand, C. Jamin, J. Clement, Y. Pennec, P. Youinou, M. Dueymes, and I.M. Roitt Increased N-linked glycosylation leading to oversialylation of monomeric immunoglobulin A1 from patients with Sjogren's syndrome Scand. J. Immunol. 51 2000 300 306
62. B.K. Choi, P. Bobrowicz, R.C. Davidson, S.R. Hamilton, D.H. Kung, H. Li, R.G. Miele, J.H. Nett, S. Wildt, and T.U. Gerngross Use of combinatorial genetic libraries to humanize N-linked glycosylation in the yeast Pichia pastoris Proc. Natl. Acad. Sci. U. S. A. 100 2003 5022 5027
63. S.R. Hamilton, P. Bobrowicz, B. Bobrowicz, R.C. Davidson, H. Li, T. Mitchell, J.H. Nett, S. Rausch, T.A. Stadheim, H. Wischnewski, S. Wildt, and T.U. Gerngross Production of complex human glycoproteins in yeast Science 301 2003 1244 1246
64. D.L. Jarvis, and E.E. Finn Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells Virology 212 1995 500 511
65. O.W. Ogonah, R.B. Freedman, N. Jenkins, and B.C. Rooney Analysis of human interferon-gamma glycoforms produced in baculovirus infected insect cells by matrix assisted laser desorption spectrometry Biochem. Soc. Trans. 23 1995 100S
66. J.K. Ma, A. Hiatt, M. Hein, N.D. Vine, F. Wang, P. Stabila, C. van Dolleweerd, K. Mostov, and T. Lehner Generation and assembly of secretory antibodies in plants Science 268 1995 716 719
67. J.K. Ma, T. Lehner, P. Stabila, C.I. Fux, and A. Hiatt Assembly of monoclonal antibodies with IgG1 and IgA heavy chain domains in transgenic tobacco plants Eur. J. Immunol. 24 1994 131 138
68. J.W. Larrick, L. Yu, C. Naftzger, S. Jaiswal, and K. Wycoff Production of secretory IgA antibodies in plants Biomol. Eng. 18 2001 87 94
69. T.S. Raju, J.B. Briggs, S.M. Borge, and A.J. Jones Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics Glycobiology 10 2000 477 486
70. U. Galili Abnormal expression of alpha-galactosyl epitopes in man. A trigger for autoimmune processes? Lancet 2 1989 358 361
71. K. Fukuta, R. Abe, T. Yokomatsu, F. Omae, M. Asanagi, and T. Makino Control of bisecting GlcNAc addition to N-linked sugar chains J. Biol. Chem. 275 2000 23456 23461
72. F.H. Routier, M.J. Davies, K. Bergemann, and E.F. Hounsell The glycosylation pattern of humanized IgGI antibody (D1.3) expressed in CHO cells Glycoconj. J. 14 1997 201 207
73. Primary immunodeficiency diseases. Report of a WHO scientific group Clin. Exp. Immunol. 109 Suppl. 1 1997 1 28
74. M. Ballow Primary immunodeficiency disorders: antibody deficiency J. Allergy Clin. Immunol. 109 2002 581 591
75. I. Vorechovsky, A.D. Webster, A. Plebani, and L. Hammarstrom Genetic linkage of IgA deficiency to the major histocompatibility complex: evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition Am. J. Hum. Genet. 64 1999 1096 1109
76. R.E. Petty, D.D. Sherry, and J.M. Johannson IgG anti-IgA1 and anti-IgA2 antibodies: their measurement by an enzyme-linked immunosorbent assay and their relationship to disease Int. Arch. Allergy Appl. Immunol. 80 1986 337 341
77. J. Koistinen, and S. Sarna Immunological abnormalities in the sera of IgA-deficient blood donors Vox Sang. 29 1975 203 213
78. G.N. Vyas, H.A. Perkins, Y.M. Yang, and G.K. Basantani Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA J. Lab. Clin. Med. 85 1975 838 842
79. L. Hammarstrom, M.A. Persson, and C.I. Smith Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA Scand. J. Immunol. 18 1983 509 513
80. C. Laschinger, F.A. Shepherd, and D.H. Naylor Anti-IgA-mediated transfusion reactions in Canada Can. Med. Assoc. J. 130 1984 141 144
81. F.H. Sennhauser, C.S. Hosking, C.L. Jones, R.A. MacDonald, N. Mermelstein, and D.M. Roberton Anti-IgA antibodies in IgA-deficient children J. Clin. Immunol. 8 1988 356 361
82. J. Bjorkander, L. Hammarstrom, C.I. Smith, R.H. Buckley, C. Cunningham-Rundles, and L.A. Hanson Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies J. Clin. Immunol. 7 1987 8 15
83. A.W. Burks, H.A. Sampson, and R.H. Buckley Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA N. Engl. J. Med. 314 1986 560 564
84. A. Ferreira, M. Garcia, C. Rodriguez, M. Lopez-Trascasa, D. Pascual Salcedo, and G. Fontan Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin Clin. Immunol. Immunopathol. 47 1988 199 207
85. A. Torano, Y. Tsuzukida, Y.S. Liu, and F.W. Putnam Location and structural significance of the oligosaccharides in human Ig-A1 and IgA2 immunoglobulins Proc. Natl. Acad. Sci. U. S. A. 74 1977 2301 2305
86. K.R. Chintalacharuvu, M. Raines, and S.L. Morrison Divergence of human alpha-chain constant region gene sequences. A novel recombinant alpha 2 gene J. Immunol. 152 1994 5299 5304